EQS-News
MediClin AG: Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
EQS-News: MediClin AG / Key word(s): 9 Month figures Offenburg, November 2, 2022 |
Group sales and Group operating result above previous year − stable capacity utilization, energy costs weigh on result
In the first nine months of 2022, MEDICLIN Aktiengesellschaft (MEDICLIN) achieved Group sales and a Group operating result above the respective comparative values of the prior-year period.
In the first nine months of 2022 Group sales of EUR 526.3 mill. were generated, which is EUR 28.2 mill. or 5.7 % more than in the first nine months of 2021. The Group operating result improved by EUR 8.7 mill. from EUR 1.4 mill. to EUR 10.1 mill. compared to the comparable prior-year period. The result was burdened by an increase in raw materials and consumables used by EUR 10.2 mill. or 11.5 %, referring in particular to higher energy costs which rose by EUR 7.1 mill. Staff costs increased by EUR 5.3 mill. or 1.7 %.
Sales increased in the segments and in the nursing care business area
In the post-acute segment sales rose by EUR 23.6 mill. or 7.9 %. The segment result improved, amounting to EUR 14.3 mill. compared to EUR 3.6 mill. in the prior-year period. The acute segment shows an increase in segment sales of EUR 3.4 mill. or 1.9 %. The segment result amounted to EUR −6.9 mill. (9M 2021: EUR −2.2 mill.). Sales of the nursing care business area improved by EUR 1.0 mill. up to EUR 13.9 mill. compared to the prior-year period.
High energy costs continue to weigh on the result
The high energy costs and rising general material costs continue to have a negative impact on earnings. "We use a variety of ways to save energy, but always under the prerequisite that the quality and hygiene requirements as well as the medical, therapeutic and nursing services are not impaired," said Dr. York Dhein, Member of the Management Board of MEDICLIN.